296 related articles for article (PubMed ID: 17661816)
1. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
[TBL] [Abstract][Full Text] [Related]
2. Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease.
Huang JS; Huang CJ; Chen SK; Chien CC; Chen CW; Lin CM
Eur J Clin Invest; 2007 Jun; 37(6):492-500. PubMed ID: 17537157
[TBL] [Abstract][Full Text] [Related]
3. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
4. [From gene to disease; Von Hippel-Lindau disease].
Hes FJ; Los M; van der Luijt RB
Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1364-7. PubMed ID: 12162174
[TBL] [Abstract][Full Text] [Related]
5. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
Pack SD; Zbar B; Pak E; Ault DO; Humphrey JS; Pham T; Hurley K; Weil RJ; Park WS; Kuzmin I; Stolle C; Glenn G; Liotta LA; Lerman MI; Klausner RD; Linehan WM; Zhuang Z
Cancer Res; 1999 Nov; 59(21):5560-4. PubMed ID: 10554035
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of von Hippel-Lindau disease.
Nordstrom-O'Brien M; van der Luijt RB; van Rooijen E; van den Ouweland AM; Majoor-Krakauer DF; Lolkema MP; van Brussel A; Voest EE; Giles RH
Hum Mutat; 2010 May; 31(5):521-37. PubMed ID: 20151405
[TBL] [Abstract][Full Text] [Related]
7. VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.
Mathó C; Sansó G; Diez B; Barontini M; Pennisi PA
Genet Test Mol Biomarkers; 2016 Dec; 20(12):771-776. PubMed ID: 27617348
[TBL] [Abstract][Full Text] [Related]
8. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
[TBL] [Abstract][Full Text] [Related]
9. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
Hes FJ; van der Luijt RB
Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
[TBL] [Abstract][Full Text] [Related]
10. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
11. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in VHL germline deletion kindred correlate with mild phenotype.
Wait SD; Vortmeyer AO; Lonser RR; Chang DT; Finn MA; Bhowmick DA; Pack SD; Oldfield EH; Zhuang Z
Ann Neurol; 2004 Feb; 55(2):236-40. PubMed ID: 14755727
[TBL] [Abstract][Full Text] [Related]
13. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
14. [von Hippel-Lindau hereditary tumor syndrome. Mutational analysis may improve prognosis].
Wiklund L; Nordling M; Engwall Y; Martinsson T; Szentgyörgyi E; Wahlström J
Lakartidningen; 1995 Mar; 92(11):1093-6. PubMed ID: 7700111
[TBL] [Abstract][Full Text] [Related]
15. Germline mutation in the von Hippel-Lindau gene in Kuwait: a clinical and molecular study.
AlFadhli SM; Mohammed B; Yassin A
Med Princ Pract; 2008; 17(5):395-9. PubMed ID: 18685280
[TBL] [Abstract][Full Text] [Related]
16. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
[TBL] [Abstract][Full Text] [Related]
17. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
[TBL] [Abstract][Full Text] [Related]
18. [Identification of a de novo mutation in a patient without von Hippel-Lindau syndrome: clinical and diagnostic implications].
Cebrián A; Ruiz Barnés P; Osorio A; Martínez-Delgado B; Benítez J; Robledo M
Neurologia; 1999; 14(7):362-5. PubMed ID: 10570625
[TBL] [Abstract][Full Text] [Related]
19. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.
Hes FJ; McKee S; Taphoorn MJ; Rehal P; van Der Luijt RB; McMahon R; van Der Smagt JJ; Dow D; Zewald RA; Whittaker J; Lips CJ; MacDonald F; Pearson PL; Maher ER
J Med Genet; 2000 Dec; 37(12):939-43. PubMed ID: 11106358
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of VHL germline mutations in Norwegian patients presenting with isolated central nervous system hemangioblastomas--a population-based study.
Rønning P; Andresen PA; Hald JK; Heimdal K; Scheie D; Schreiner T; Helseth E
Acta Neurol Scand; 2010 Aug; 122(2):124-31. PubMed ID: 19814753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
